コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ssure control, a sodium-restricted diet, and antihypertensive agents).
2 ne parenteral (bolus or continuous infusion) antihypertensive agent.
3 renin to be approved for clinical use as an antihypertensive agent.
4 doxazosin is a safe and effective third-line antihypertensive agent.
5 in a 6-month period and were taking a single antihypertensive agent.
6 ctive synthesis of indolodioxane U86192A, an antihypertensive agent.
7 irstline agents and low-dose therapy for all antihypertensive agents.
8 ortic surgery, compared to patients on other antihypertensive agents.
9 ide-effect profiles prior to clinical use as antihypertensive agents.
10 latency of cancer, and heterogeneous use of antihypertensive agents.
11 pon reduction of MI when compared with other antihypertensive agents.
12 educe LV mass to a greater extent than other antihypertensive agents.
13 3 inhibitors might be therapeutically useful antihypertensive agents.
14 function to a greater extent than can other antihypertensive agents.
15 lism that are not shared by other classes of antihypertensive agents.
16 hat modifiers of WNK signaling may be potent antihypertensive agents.
17 A/C-selective antagonists might be desirable antihypertensive agents.
18 vailable ACE inhibitors or other widely used antihypertensive agents.
19 tension and preoperative use of two or fewer antihypertensive agents.
20 promising natural source of antioxidants and antihypertensive agents.
21 e of specific CLCNKB antagonists as diuretic antihypertensive agents.
22 with SR-HTN and A-HTN who reported use of an antihypertensive agent, 94% were on at least one of the
23 t races and variation in the degree to which antihypertensive agents affect systemic blood pressure a
24 own whether continuous use of hydralazine-an antihypertensive agent (AHA) with notable anti-neoplasti
27 testinal therapeutic system) as a third-line antihypertensive agent among 10,069 participants in the
28 lockers against 30,139 patients taking other antihypertensive agents and 3,987 patients receiving pla
29 studies have proposed an association between antihypertensive agents and cancer, but due to limitatio
31 th frailty who were receiving treatment with antihypertensive agents and had a systolic blood pressur
35 ll, extensive out-of-study use of statin and antihypertensive agents, and reduction in the use of stu
36 ng-standing groups of therapeutics including antihypertensive agents, antithrombotic agents, beta-blo
39 ; n = 99, DTG-D arm) without hypertension or antihypertensive agents at baseline, incidence rates per
41 were on at least one of the major classes of antihypertensive agents, but only 44% were on >/=2 class
42 thesized potentially carcinogenic effects of antihypertensive agents, but to date there is no convinc
45 and evaluated the effects of two classes of antihypertensive agents commonly used in the clinical se
46 linical trials, blood pressure lowering with antihypertensive agents compared with control was signif
48 ous hypoglycemia among users of any class of antihypertensive agents compared with nonusers of antihy
49 or intake of medications such as aspirin and antihypertensive agents did not change the associations
50 betic agents, and hypertension and/or use of antihypertensive agents did not change within or between
52 omplicated hypertension, compared with other antihypertensive agents, first-line therapy with beta-bl
53 ypertensive patients, safety and efficacy of antihypertensive agents for coronary artery disease (CAD
54 erting enzyme (ACE) inhibitors are effective antihypertensive agents for patients with diabetes melli
56 was a large increase in the use of multiple antihypertensive agents (from 36.8% to 47.7%, P(trend)<0
58 nonlobar intracerebral hemorrhage (ICH), and antihypertensive agents have distinct biological implica
59 spective randomized clinical trials (RCT) of antihypertensive agents have focused on cardiovascular a
60 fficacy of drugs from three major classes of antihypertensive agents; however, comparative trials hav
61 Benefit has been demonstrated with multiple antihypertensive agents; however, some studies suggest a
62 ge-matched SHR and WKY were treated with the antihypertensive agent hydralazine administered in the d
63 urve." By decreasing the blood pressure, all antihypertensive agents improve aortic distensibility, b
64 ood pressure and (2) the effectiveness of an antihypertensive agent in ameliorating renal injury may
65 d nisoldipine with enalapril as a first-line antihypertensive agent in terms of the prevention and pr
69 er incidence of epilepsy compared with other antihypertensive agents in hypertensive patients with no
71 eptor (alpha2-AR) agonists have been used as antihypertensive agents, in the management of drug withd
72 ith aliskiren is equivalent to commonly used antihypertensive agents including diuretics, ACE inhibit
73 on three, or controlled with at least four, antihypertensive agents (including a diuretic), is assoc
75 ere receiving stable doses of at least three antihypertensive agents, including a diuretic, to receiv
76 and nifedipine, which are clinically used as antihypertensive agents, inhibited the photolabeling of
77 shing relative benefit or harm from specific antihypertensive agents is limited by the complex array
78 n), an FDA-approved drug formerly used as an antihypertensive agent, is capable of markedly increasin
79 ion-uncontrolled hypertension with 3 or more antihypertensive agents-is increasingly common in clinic
80 receptor blockers have emerged as effective antihypertensive agents, it is not known how efficacious
82 lood pressure data and several pharmacologic antihypertensive agents makes early detection and treatm
84 ecular pathways by which specific classes of antihypertensive agents may promote, or protect, against
86 , in an animal model of type 2 diabetes, the antihypertensive agent moxonidine induces a beneficial e
87 alone (n = 201) or in combination with other antihypertensive agents (n = 467), and none (n = 208).
88 unction score, need for vasopressors, use of antihypertensive agents, need for mechanical ventilation
89 oal despite concurrent use of at least three antihypertensive agents of different classes, including
90 controlled blood pressure despite use of >=5 antihypertensive agents of different classes, including
91 rolled blood pressure despite the use of >=3 antihypertensive agents of different classes, including
92 rtension and the vasculoprotective effect of antihypertensive agents of different mechanisms of actio
95 e identified who require treatment with >= 2 antihypertensive agents or have a high number of IA that
96 that CCBs offer a major advantage over other antihypertensive agents or that they should be recommend
98 ups consisted of either placebo, alternative antihypertensive agents, or higher blood pressure target
99 B and C: older age (P < .003), prior/current antihypertensive agents (P = .005), and lower registrati
100 ical therapy (with antiplatelet, statin, and antihypertensive agents plus lifestyle modification), me
103 implications for the regulatory approval of antihypertensive agents, revisions of treatment guidelin
104 e purpose of this study was to determine the antihypertensive agent(s) more likely to mitigate an exa
105 tients' medications from mibefradil to other antihypertensive agents should be aware of these potenti
106 k activation induced by progesterone and the antihypertensive agent spironolactone, and the binding s
107 iabetic patients, such as insulin analogues, antihypertensive agents, statins, and hypoglycemic agent
108 inhibitors (RASi) is superior to alternative antihypertensive agents such as calcium channel blockers
111 nts in both groups also received concomitant antihypertensive agents that did not inhibit the renin-a
112 ertrophy and arterial mass better than other antihypertensive agents that lower blood pressure equall
113 analyses suggests that ARBs, while effective antihypertensive agents that protect against risk of str
115 and multidrug users) with that of any other antihypertensive agent, the adjusted RR was 1.42 (95% CI
116 ypertension and in those treated with 1 or 2 antihypertensive agents, the value of exercise and diet
118 dy mass index, cigarette smoking, and use of antihypertensive agents, they found that glucose was a s
119 besartan, amlodipine, or placebo, with other antihypertensive agents to a BP goal of < or =135/85 mmH
121 ise-driven reports, we found that drugs from antihypertensives agents, urologicals, and antithromboti
122 ular events, quality of life, rate of single antihypertensive agent use, lipid levels, progression to
128 bined therapy (with rosuvastatin and the two antihypertensive agents) with the 3168 participants assi